Pulmonary candidiasis caused by Candida albicans in a Greek tortoise (Testudo graeca) and treatment with intrapulmonary amphotericin B

Journal of Zoo and Wildlife Medicine

Volumn 32, Issue 3, 2001, Pages 352-359

  Hernandez Divers, Stephen J ^a,b  

^a Exotic Animal Center   (United Kingdom)

^b UNIVERSITY OF GEORGIA   (United States)

Author keywords

Amphotericin B; Candida; Chelonia; Greek tortoise; Mycosis; Pneumonia; Testudo graeca

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; KETOCONAZOLE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CANDIDIASIS; CASE REPORT; DRUG EFFECT; ENZYMOLOGY; FEMALE; INTRALESIONAL DRUG ADMINISTRATION; LIVER; LUNG MYCOSIS; TREATMENT OUTCOME; TURTLE;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; ANTIFUNGAL AGENTS; CANDIDIASIS; FEMALE; INFUSIONS, INTRALESIONAL; KETOCONAZOLE; LIVER; LUNG DISEASES, FUNGAL; TREATMENT OUTCOME; TURTLES;

EID: 0038679011     PISSN: 10427260     EISSN: None     Source Type: Journal    
DOI: 10.1638/1042-7260(2001)032[0352:PCCBCA]2.0.CO;2     Document Type: Article

References (23)

1. Bojanus, L. H. 1970. Anatome Testudinis Europaeae. Society for the Study of Amphibians and Reptiles, Athens, Ohio.
2. Bywater, R. J. 1991. Antifungal and antiviral agents. In: Brander, G. C., D. M. Pugh, R. J. Bywater, and W. L. Jenkins (eds.). Veterinary Applied Pharmacology and Therapeutics. Baillière Tindall, London, England. Pp. 574-576.
3. Clercx, C., K. McEntree, F. Snaps, E. Jacquinet, and F. Coignoui. 1996. Bronchopulmonary and disseminated granulomatous disease associated with Aspergillus fumigatus and Candida species infection in a golden retriever. J. Am. Anim. Hosp. Assoc. 32: 139-145.
4. Diot, P., B. Rivoire, A. Le Pape, E. Lemarie, D. Dire, Y. Furet, M. Breteau, and G. C. Smaldone. 1995. Deposition of amphotericin B aerosols in pulmonary aspergilloma. Eur. Respir. J. 8: 1263-1268.
5. Frye, F. L. 1991. Fungal, actinomycete, bacterial, rickettsial and viral diseases. In: Frye, F. L. (ed.). Biomedical and Surgical Aspects of Captive Reptile Husbandry, 2nd ed. Kreiger Publishing Co., Malabar, Florida. Pp. 101-157.
6. Fudge, A. M. 2000. Laboratory Medicine - Avian and Exotic Pets. W. B. Saunders Co., Philadelphia, Pennsylvania.
7. Gryn, J., J. Goldberg, E. Johnson, J. Siegel, and J. Inzerillo. 1993. The toxicity of daily inhaled amphotericin B. Am. J. Clin. Oncol. 16: 43-46.
8. Jackson, O. F. 1980. Weight and measurement data on tortoises (Testudo graeca and Testudo hermanni) and their relationship to health. J. Small. Anim. Pract. 21: 409.
9. Jacobsen, E. R., J. L. Cheatwood, and L. K. Maxwell. 2000. Mycotic disease of reptiles. Semin. Avian Exotic Pet Med. 9: 94-101.
10. Jessup, C., G. Reyes, A. Fothergill, D. McCarthy, M. Rinaldi, S. Messer, M. Pfaller, and M. Ghannoum. 2000. A head-on comparison of the in vitro antifungal activity of conventional and lipid-based amphotericin B: a multicenter study. J. Chemother. 12: 22-29.
11. Koizumi, T., K. Kubo, T. Kaneki, M. Hanaoka, T. Hayano, T. Miyahara, K. Okada, K. Fujimoto, H. Yamamoto, T. Kobayashi, and M. Sekiguchi. 1998. Pharmacokinetic evaluation of amphotericin B in lung tissue: lung lymph distribution after intravenous injection and air space distribution after aerosolization and inhalation of amphotericin B. Antimicrob. Agents Chemother. 42: 1597-1600.
12. Kostka, V. M., L. Hoffman, E. Balks, U. Eskens, and N. Wimmershof. 1997. A review of the literature and investigations on the prevalence and consequences of yeasts in reptiles. Vet. Rec. 140: 282-287.
13. Mader, D. R. 1996. Reptile Medicine and Surgery. W. B. Saunders Co., Philadelphia, Pennsylvania.
14. Niki, Y., E. M. Bernard, H. J. Schmitt, W. P. Tong, F. F. Edwards, and D. Armstrong. 1990. Pharmacokinetics of aerosol amphotericin B in rats. Antimicrob. Agents Chemother. 34: 29-32.
15. Oehling, A., M. Giron, and M. L. Subira. Aerosol chemotherapy in bronchopulmonary candidiasis. Respiration 32: 179-184.
16. Orosz, S. E., and D. L. Frazier. 1995. Antifungal agents: a review of their pharmacology and therapeutic indications. J. Avian Med. Surg. 9: 8-18.
17. Page, C. D., M. Mautino, H. Derendorf, and W. Mechlinski. 1991. Multiple dose pharmacokinetics of ketoconazole administered orally to gopher tortoises (Gopherus polyphemus). J. Zoo Wildl. Med. 22: 191-198.
18. Page, C. D., M. Mautino, J. R. Meyer, and W. Mechlinski. 1988. Preliminary pharmacokinetics of ketoconazole in gopher tortoises (Gopherus polyphemus). J. Vet. Pharmacol. Ther. 11: 397-401.
19. Rodriguez, R. J., and D. Acosta. 1995. Comparison of ketoconazole- and fluconazole-induced hepatotoxicity in a primary culture system of rat hepatocytes. Toxicology 96: 83-92.
20. Ruijgrok, E. J., A. G. Vulto, and E. W. Van Etten. 2000. Aerosol delivery of amphotericin B desoxycholate (Fungizone) and liposomal amphotericin B (AmBisome): aerosol characteristics and in-vivo amphotericin B deposition in rats. J. Pharm. Pharmacol. 52: 619-627.
21. Shelly, M. A., R. H. Poe, and L. B. Kapner. Pul monary mycetoma due to Candida albicans: case report and review. Clin. Infect. Dis. 22: 133-135.
22. Stoakes, L. C. 1992. Respiratory system. In: Beynon, P. H., M. P. C. Lawton, and J. E. Cooper (eds.). Manual of Reptiles. British Small Animal Veterinary Association, Cheltenham, Gloucestershire, United Kingdom. Pp. 88-100.
23. Van Cauteren, H., A. Lampo, J. Vandenberghe, P. Vanparys, W. Coussement, R. De Coster, and R. Marsboom. 1989. Toxicological profile and safety evaluation of antifungal azole derivatives. Mycoses 32(Suppl. 1): 60-66.